10

May

2022

15:00

BST

16:00

CEST

Webinar

How Can I Simultaneously Optimize TAVI and Future Coronary Access? Lifetime Management of Patients With Severe AS Without Compromise

Average (ratings)
No ratings
Your rating

Overview

Coronary Artery Disease (CAD) is present in 60–70% of current TAVI patients1. Future TAVI patients will be treated at a younger age with longer life expectancy who may develop CAD. Therefore easy coronary access is paramount to treat current and future patient populations safely2.

This webinar aims to illustrate how to optimize procedural outcomes by using commissural alignment to preserve coronary access3,4 and increase options for possible future interventions.

 

Faculty:


Mohamed Abdel-Wahab

Mohamed Abdel-Wahab


Flavio Ribichini

Flavio Ribichini


Joanna J Wykrzykowska

Joanna J Wykrzykowska


Dr Rik van der Werf

Dr Rik van der Werf

This webinar is supported by

Agenda

Welcome & Intro

Flavio Luciano Ribichini
16:00 - 16:02 CEST

Coronary access after TAVI: Why bother?

Mohamed Abdel-Wahab
16:02 - 16:12 CEST

Live Case Live from Groningen, Netherlands

Joanna Wykrzykowska
16:12 - 16:42 CEST

Faculty Discussion

All faculty
16:42 - 16:58 CEST

Summary

Mohammed Abdel-Wahab
16:58 - 17:00 CEST

Key Learning Objectives

  • Step by step demonstration how to perform commissural alignment
  • Understand current and predicted trends in TAVI with respect to preserving coronary access
  • Share experience and discuss lifetime management of patients with severe AS with consideration of factors for choosing valves in low risk populations

Target Audience

  • Interventional Cardiologists
  • Cardiac Surgeons
  • Interventional Fellows
  • TAVI Experts
  • Complex PCI experts

Faculty Biographies


Joanna J Wykrzykowska

Joanna J Wykrzykowska

Dr Joanna J Wykrzykowska obtained her Doctor of Medicine degree from Harvard Medical School and Massachusetts Institute of Technology, Boston MA in 2002. She completed her internal medicine residency at the Massachusetts General Hospital and her Cardiology Fellowship at Beth Israel Deaconess Medical Center (both Harvard teaching hospitals). She continued and completed her Interventional Cardiology fellowship at Erasmus MC, Rotterdam NL in 2010 and obtained her PhD in interventional cardiology in 2011 under the supervision of Prof Patrick Serruys. She worked as staff Interventional Cardiologist at the Amsterdam University Medical Center till 2020 where she was the principal investigator of multiple clinical trials, including AIDA trial (published in NEJM).

Since 2020 Dr Wykrzykowska is an interventional cardiologist and since 2022 holds the title of an Associate Professor of Interventional Cardiology at the University Medical Center in Groningen. 

Her research focusses on predictors of disease progression and clinical outcomes using imaging parameters and artificial intelligence techniques in aortic stenosis. She is a promotor of 19 PhD candidates and has authored 272 papers in interventional cardiology. Her H-index is 41. She is also a member of the Eurointervention editorial board (Section editor), member of the ESC Programme Committee and EAPCI Patient Advocacy Committee and is on the faculty of EuroPCR, TCT, London valves, New York valves and ESC congresses. She continues to be steering committee member, national lead and principal investigator of many clinical trials in interventional cardiology continuing to make important contributions to the scientific progress in the field of cardiology.

View full profile

Dr Rik van der Werf

Dr Rik van der Werf

View full profile

Flavio Ribichini

Flavio Ribichini

Prof Flavio Ribichini is a Professor of Cardiovascular Medicine and Director of the Division of Cardiovascular Medicine at the University of Verona, Verona, IT.

Prof Ribichini is an interventionalist dedicated to vascular angioplaties, valvular replacement and congenital intervention.

View full profile

Mohamed Abdel-Wahab

Mohamed Abdel-Wahab

Internationally renowned interventional cardiologist specialized in TAVI and complex coronary interventions. Head of the department of structural heart disease at Heart Center Leipzig, the largest European center in terms of number of TAVI procedures. Professor Abdel-Wahab has contributed to over 200 papers in the field of interventional cardiology in high profile peer review journals.

View full profile

Key References

1. T. Lefèvre, A.P. Kappetein, E. Wolner, et al., PARTNER EY Investigator Group
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study

2. Short-and-Long-Term Outcomes after Coronary Rotational Atherectomy in Patients Treated with Trans-Catheter Aortic Valve Implantation.
Lunardi M, Pighi M, Venturi G, Del Sole PA, Pesarini G, Mainardi A, Scarsini R, Ferrero V, Gottin L, Ribichini F.
J Clin Med. 2020 Dec 31;10(1):112. doi: 10.3390/jcm10010112.
PMID: 33396185 Free PMC article.

3. Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves.
Bieliauskas G, Wong I, Bajoras V, Wang X, Kofoed KF, De Backer O, Søndergaard L.
JACC Cardiovasc Interv. 2021 Sep 8:S1936-8798(21)01233-4. doi: 10.1016/j.jcin.2021.06.033. Online ahead of print.
PMID: 34538602

4. Commissural Alignment of the ACURATE neo Valve in Transcatheter Aortic Valve Replacement.
Kitamura M, Wilde J, Gohmann R, Majunke N, Gutberlet M, Shibata M, Kiefer P, Desch S, Thiele H, Holzhey D, Abdel-Wahab M.
JACC Cardiovasc Interv. 2021 Aug 9;14(15):1740-1742. doi: 10.1016/j.jcin.2021.05.037.
PMID: 34353607 No abstract available.